Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,108 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,158)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07101900 | 68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses | enrolling by invitation | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT05913999 | Serial PET MPI in Patients Undergoing Cancer Treatment | enrolling by invitation | — | 60 | University of California, Los AngelesOTHER | 1 | Aug 6, 2025 |
| clinicaltrials |
| NCT07107815 | A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics | enrolling by invitation | — | 250 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07091565 | Supporting Sexual Recovery in Women With Bladder Cancer(SPARC) | enrolling by invitation | — | 60 | King's College LondonOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07072676 | The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.(Risk of fall) | enrolling by invitation | N/A | 30 | LMU KlinikumOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT06391749 | Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)(K-ACCELERATE) | enrolling by invitation | — | 1,000 | Gene SolutionsINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07060625 | The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery | enrolling by invitation | — | 308 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT07058753 | Prehabilitation in Ovarian Cancer Patients During Chemiotherapy Before Cytoreductive Surgery.(PREHONED) | enrolling by invitation | N/A | 100 | Medical University of SilesiaOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT07056205 | Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer. | enrolling by invitation | — | 100 | Sohag UniversityOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07051265 | Effect of Transcutaneous Electrical Nerve Stimulation or Acupressure on Pain in Patients With Head and Neck Cancer | enrolling by invitation | N/A | 240 | Kaohsiung Veterans General Hospital.OTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07052448 | The Efficacy of Sequential RT After Triple Therapy for uHCC | enrolling by invitation | — | 35 | Fujian Provincial HospitalOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT07046832 | Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy | enrolling by invitation | N/A | 104 | MediView XR, Inc.INDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07047937 | Explainable Machine Learning for Predicting Early Gastric Cancer | enrolling by invitation | — | 10 | Wenzhou Central HospitalOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT06472765 | Vaginal Ecosystem and Network in the United States Study(VENUS) | enrolling by invitation | — | 3,250 | Vaginal Biome ScienceOTHER | 2 | Jul 1, 2025 | clinicaltrials |
| NCT07042841 | AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer | enrolling by invitation | — | 300 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT06896110 | Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma | enrolling by invitation | Phase 1 | 34 | Andrew P. GrovesOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT07034859 | Cabergoline in the Management of Nonfunctioning Pituitary Adenoma | enrolling by invitation | Phase 4 | 30 | National Taiwan University HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07023848 | PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors | enrolling by invitation | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07023861 | The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies | enrolling by invitation | Early Phase 1 | 20 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07023068 | ⁶⁸Ga-DPA in the Lung Cancer Diagnosis | enrolling by invitation | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT07016737 | Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy(ESO-Nanjing12) | enrolling by invitation | Phase 3 | 79 | Ye jinjunOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT06276140 | Iron-deficiency Anaemia and Its Impact on Recovery After Colorectal Cancer Surgery(ID-COLO) | enrolling by invitation | — | 200 | Oncology Institute of VojvodinaOTHER_GOV | 1 | Jun 4, 2025 | clinicaltrials |
| NCT03031249 | Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia | enrolling by invitation | Phase 1 / Phase 2 | 80 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06997458 | Liquid BiOpsy, Lung and Colon Cancer in AndaluciA(LOLA-PROJECT) | enrolling by invitation | — | 500 | Fundación Pública Andaluza para la Investigación Biomédica Andalucía OrientalOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT04165460 | Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients | enrolling by invitation | N/A | 92 | National Institute of CancerologíaOTHER_GOV | 1 | May 28, 2025 | clinicaltrials |
| NCT06990178 | Adaptive Neoadjuvant Therapy for Esophageal Cancer | enrolling by invitation | N/A | 43 | Cancer Hospital Chinese Academy of Medical Science, Shenzhen CenterOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT06984055 | Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia | enrolling by invitation | — | 600 | Changhai HospitalOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06419179 | Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)(GUIDANCE) | enrolling by invitation | Phase 2 | 29 | University of CologneOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06967662 | Selective Plasma Adsorption of Extracellular DNA in Prevention of Intraoperative Metastasis in Pancreatic Cancer (Pilot Study)(INTRACOR_pilot) | enrolling by invitation | N/A | 28 | Ilyinskaya Hospital, JSCOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT06703944 | Risk Model for Metastasis Detection of Neuroblastoma(NB) | enrolling by invitation | — | 500 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06761534 | Development and Verification of a Screening Tool for Comprehensive Geriatric Assessment of Elderly Tumor Patients | enrolling by invitation | — | 678 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06697327 | Daunorubicin + Cytarabine + Venetoclax in de Novo AML | enrolling by invitation | N/A | 94 | Anhui Medical UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06261190 | Active Surveillance for Low-risk Papillary Thyroid Carcinoma(MAeSTro-EXP) | enrolling by invitation | — | 499 | National Cancer Center, KoreaOTHER_GOV | 1 | May 11, 2025 | clinicaltrials |
| NCT06962449 | Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer(REALM-Post) | enrolling by invitation | — | 500 | Shanghai Chest HospitalOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT06963060 | Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)(GALENT-BT) | enrolling by invitation | Phase 2 | 44 | Wei GongOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT06958445 | Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy(SAFE) | enrolling by invitation | Phase 2 | 90 | Taipei City HospitalOTHER_GOV | 1 | May 6, 2025 | clinicaltrials |
| NCT06958640 | Da Qing Offspring Study | enrolling by invitation | — | 5,000 | China-Japan Friendship HospitalOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT02646839 | KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children | enrolling by invitation | Phase 2 | 50 | Michael PulsipherOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT04836390 | Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant(EXCEL) | enrolling by invitation | Phase 2 | 30 | Michael PulsipherOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT06947096 | Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients | enrolling by invitation | — | 120 | Qun ZhaoOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06829836 | Can You Breathe Your Way To Better Health? | enrolling by invitation | N/A | 36 | University of Northern ColoradoOTHER | 1 | Apr 25, 2025 | clinicaltrials |
| NCT06943313 | Breast Cancer PET/CT Imaging With 68Ga-pAKTi | enrolling by invitation | — | 20 | Fudan UniversityOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT03423303 | A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)(ProScreen) | enrolling by invitation | N/A | 17,400 | Tampere UniversityOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT04098640 | Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast Cancer | enrolling by invitation | N/A | 200 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06931613 | Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment | enrolling by invitation | Phase 2 | 20 | St. Petersburg State Pavlov Medical UniversityOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06931808 | Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer | enrolling by invitation | Phase 4 | 20 | First Affiliated Hospital of Ningbo UniversityNETWORK | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06923020 | Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer. | enrolling by invitation | — | 200 | Yongxu JiaOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT06807515 | Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission | enrolling by invitation | — | 24 | Thong Chai Institute of Medical ResearchOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06917794 | Development of Polygenic Risk Scores in Colon Cancer Patients Through the Study of Ancestry and Diversity in Genetic Maps of the Brazilian Population - ORIGEM Project(ORIGEM) | enrolling by invitation | — | 500 | D'Or Institute for Research and EducationOTHER | 1 | Apr 8, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 8, 2025source: clinicaltrials